TCT 709: The Novel Hybrid Nano-coating Ni-Ti stent for below-the-knee atherosclerotic disease: The Newest “Leave the Right Thing Behind”Concept

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker’s Bureau - Stryker Corporation
• - Global Vascular